跳轉至內容
Merck
全部照片(2)

重要文件

E9033

Sigma-Aldrich

pFLAG-Myc-CMV-22 Expression Vector

Shuttle vector for transient or stable intracellular expression of dual tagged N-terminal FLAG and C-terminal c-myc fusion proteins

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352200

籤條

FLAG® tagged
c-Myc tagged (C-terminal)

等級

for molecular biology

形狀

buffered aqueous solution

運輸包裝

dry ice

儲存溫度

−20°C

一般說明

The pFLAG-Myc-CMV-22 Expression Vector is a 6.3 kb derivative of pCMV5 used to establish transient or stable intracellular expression of dual-tagged N-terminal FLAG® and C-terminal c-myc fusion proteins in mammalian cells. The vector encodes the FLAG epitope (Asp-Tyr-Lys-Xaa-Xaa-Asp) and a c-myc epitope (EQKLISEEDL) upstream and downstream of the multiple cloning sites, respectively.

pFLAG-Myc-CMV-22 Expression Vector is a shuttle vector for E. coli and mammalian cells. Efficiency of replication is optimal when using an SV40 T antigen expressing host.

The pFLAG-CMV-4-BAP Control Plasmid is a 7.7 kb derivative of pCMV5 used for transient intracellular expression of N-terminal Met-FLAG bacterial alkaline phosphatase fusion protein in mammalian cells.

Vector Maps and Sequences

應用

The pFLAG-Myc-CMV-20 Expression Vector is suitable for stable cytoplasmic expression of C-terminal c-myc N-terminal Met-FLAG® fusion proteins in mammalian cells.

成分

pFLAG-Myc-CMV-22 Expression Vector 20 μg (E5901) is supplied as 0.5 mg/ml in 10 mM Tris-HCl (pH 8.0) with 1 mM EDTA.
pFLAG-CMV-4-BAP Control Plasmid 20 μg (C4722) is supplied as 0.5 mg/ml in 10 mM Tris-HCl (pH 8.0) with 1 mM EDTA.

原則

The promoter-regulatory region of the human cytomegalovirus drives transcription of FLAG® and c-myc fusion constructs. The aminoglycoside phosphotransferase II gene (Neo-r) confers resistance to aminoglycosides such as G418 allowing for selection of stable transfectants.

法律資訊

FLAG is a registered trademark of Merck KGaA, Darmstadt, Germany
pFLAG-CMV is a trademark of Sigma-Aldrich Co. LLC
pFLAG-Myc-CMV is a trademark of Sigma-Aldrich Co. LLC

儲存類別代碼

10 - Combustible liquids


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Shinsuke Izumaru et al.
International journal of oncology, 24(5), 1245-1255 (2004-04-07)
DNA damage via radiation exposure and administration of chemotherapeutic agents induce apoptosis, which is a basic mechanism for non-surgical anti-cancer treatment. We analyzed ionizing radiation (IR)- or ultraviolet (UV)-induced apoptosis in human laryngeal carcinoma (HEp-2) and uterine cervical carcinoma (HeLa)
Maria Filippova et al.
Journal of virology, 83(1), 210-227 (2008-10-10)
High-risk strains of human papillomavirus (HPV) such as HPV type 16 (HPV16) and HPV18 are causative agents of most human cervical carcinomas. E6, one of the oncogenes encoded by HPV16, possesses a number of biological and transforming functions. We have
Maria Filippova et al.
Journal of virology, 81(8), 4116-4129 (2007-02-03)
Human papillomavirus type 16 (HPV-16) has developed numerous ways to modulate host-initiated immune mechanisms. The HPV-16 E6 oncoprotein, for example, can modulate the cellular level, and consequently the activity, of procaspase 8, thus modifying the cellular response to cytokines of
Erin L Whitaker et al.
Cytokine, 56(2), 272-281 (2011-08-17)
Interleukin-24 (mda-7/IL-24) is a cytokine in the IL-10 family that has received a great deal of attention for its properties as a tumor suppressor and as a potential treatment for cancer. In this study, we have identified and characterized five

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務